Literature DB >> 5944276

Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

M F Woodruff, J L Boak.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5944276      PMCID: PMC2008959          DOI: 10.1038/bjc.1966.42

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  8 in total

1.  [STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM].

Authors:  B N HALPERN; A R PREVOT; G BIOZZI; C STIFFEL; D MOUTON; J C MORARD; Y BOUTHILLIER; C DECREUSEFOND
Journal:  J Reticuloendothel Soc       Date:  1964-01

2.  Protective activity of fractions of tubercle bacilli against isologous tumours in mice.

Authors:  D W WEISS; R S BONHAG; K B DEOME
Journal:  Nature       Date:  1961-06-03       Impact factor: 49.962

3.  A method for the production of viable cell suspensions from solid tumors.

Authors:  E A BOYSE
Journal:  Transplant Bull       Date:  1960-01

4.  [Effect of inoculation with Calmette-Guerin bacillus on the development of Ehrlich ascites tumor in the mouse].

Authors:  G BIOZZI; C STIFFEL; B N HALPERN; D MOUTON
Journal:  C R Seances Soc Biol Fil       Date:  1959

5.  Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.

Authors:  L J OLD; D A CLARKE; B BENACERRAF
Journal:  Nature       Date:  1959-07-25       Impact factor: 49.962

6.  [Effect of stimulation of the reticuloendothelial system by inoculation of the Calmette-Guerin bacillus on the development of the atypical Guerin T-S epithelioma in the rat].

Authors:  B N HALPERN; G BIOZZI; C STIFFEL; D MOUTON
Journal:  C R Seances Soc Biol Fil       Date:  1959

7.  Stimulation of host defense against experimental cancer. I. Zymosan and sarcoma 180 in mice.

Authors:  W T BRADNER; D A CLARKE; C C STOCK
Journal:  Cancer Res       Date:  1958-04       Impact factor: 12.701

8.  The significance of splenomegaly in tumour-bearing mice.

Authors:  M F WOODRUFF; M O SYMES
Journal:  Br J Cancer       Date:  1962-03       Impact factor: 7.640

  8 in total
  70 in total

1.  The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.

Authors:  J P Minton; J L Rossio; B Dixon; M C Dodd
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

2.  A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system.

Authors:  W H McBride; J Dawes; N Dunbar; A Ghaffar; M F Woodruff
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

3.  A lipid chemotactic factor from anaerobic coryneform bacteria including Corynebacterium parvum with activity for macrophages and monocytes.

Authors:  R J Russell; R J McInroy; P C Wilkinson; R G White
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

Review 4.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

5.  Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.

Authors:  M F Woodruff; W H McBride; N Dunbar
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

6.  Properties of an antigenic polysaccharide from Corynebacterium parvum.

Authors:  J Dawes; S J Tuach; W H McBride
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

7.  Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine.

Authors:  E A Murano; C S Cummins
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  The effect of intravenous Corynebacterium parvum on gut associated mononuclear phagocytes in normal and tumour bearing rats.

Authors:  R G Souter; H W Steer
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

10.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.